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Obesity Phenotype and Coronary Heart Disease Risk as Estimated 
by the Framingham Risk Score 
There are conflicting data as to whether general or abdominal obesity is a better predictor 
of cardiovascular risk. This cross-sectional study involved 4,573 subjects aged 30 to 74 yr 
who participated in the Fourth Korea National Health and Nutrition Examination Survey 
conducted in 2008. Obesity phenotype was classified by means of body mass index (BMI) 
and waist circumference (WC), and participants were categorized into 4 groups. Individuals’ 
10-yr risk of coronary heart diseases (CHD) was determined from the Framingham risk 
score. Subjects with obese WC had a higher proportion of high risk for CHD compared to 
the normal WC group, irrespective of BMI level. Relative to subjects with normal BMI/
normal WC, the adjusted odds ratios (ORs) of normal BMI/obese WC group (OR 2.93 [1.70, 
5.04] and OR 3.10 [1.49, 6.46]) for CHD risk in male were higher than obese BMI/obese 
WC group (OR 1.91 [1.40, 2.61] and OR 1.70 [1.16, 2.47]), whereas the adjusted ORs of 
obese BMI/obese WC group (OR 1.94 [1.24, 3.04] and OR 3.92 [1.75, 8.78]) were higher 
than the others in female. Subjects with obese BMI/normal WC were not significantly 
associated with 10-yr CHD risk in men (P = 0.449 and P = 0.067) and women (P = 0.702 
and P = 0.658). WC is associated with increased CHD risk regardless of the level of BMI. 
Men with normal BMI and obese WC tend to be associated with CHD risk than those with 
obese BMI and obese WC.
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INTRODUCTION
The increasing prevalence of obesity is a major public health 
problem worldwide. Obesity is associated with diabetes melli-
tus and cardiovascular diseases (CVD) such as ischemic heart 
disease and stroke, as well as major risk factors for metabolic dis-
orders (1). The most popular index of obesity is the body mass 
index (BMI) or waist circumference (WC), and most epidemio-
logic studies on obesity have also used BMI or WC for the mea-
surement of body fatness. However, there are conflicting data 
as to whether the general obesity assessed by BMI or the central 
obesity assessed by WC is more closely associated with cardio-
vascular risk (2).
  Previous studies have reported that both BMI and WC values 
can identify cardiovascular risk equally effectively (3, 4). On the 
other hand, some studies have demonstrated that the WC is a 
superior marker for predicting cardiovascular risk than BMI (5-
7). In addition, several studies have shown that even among peo-
ple with normal BMI, wide ranges were observed for adiposity 
or metabolic variables. The issue remained whether this variabil-
ity was associated with cardiovascular risk factors (8-10). BMI 
and WC could indicate different health risks of patients in clini-
cal practice. However, little is known about the independent ef-
fects of BMI and WC, and the results remain controversial (2, 11). 
The findings of a high WC in some individuals with normal BMI 
or a high BMI in others with normal WC have been frequently 
encountered. When clinicians meet such patients, there is some 
difficulty in assessing the cardiovascular risk according to the 
obesity phenotype.
  The present study was conducted to evaluate the obesity phe-
notype presented by BMI and WC and to assess their associa-
tion with coronary heart diseases (CHD) risk among various 
CVD outcomes as estimated by the Framingham risk score in 
Korean adults.
 
MATERIALS AND METHODS
Study subjects
The present study is based on data acquired in the fourth Korea 
National Health and Nutrition Examination Survey (KNHANES 
IV-2) conducted in 2008. The KNHANES has been conducted 
periodically since 1998 to assess the health and nutritional sta-
tus of the non-institutionalized civilian population of Korea. The 
KNHANES IV was a cross-sectional and nationally representa-Park YS, et al.  •  Obesity Phenotype and Coronary Heart Disease Risk
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tive survey conducted by the Korea Centers for Disease Control 
and Prevention from 2007 to 2009. The sampling frame was 
based on the population census survey conducted by the Sta-
tistics Korea in 2005. A stratified, multistage probability sam-
pling design was used for the selection of household units. In 
the KNHANES IV-2, there were 264,186 primary sampling units 
by proportional allocation, each of which contained about 60 
households. Two hundred sampling frames from primary sam-
pling units were randomly sampled and 23 households from 
each sampling frame were sampled using a systemic sampling 
method. Finally, 12,528 individuals in 4,600 households were 
sampled and 9,744 of them participated in the surveys (overall 
participation rate 77.8%). Of the 5,711 subjects aged 30 to 74 yr, 
participants with previous diagnoses of stroke, ischemic heart 
disease, or chronic renal failure (n = 255) and current treatment 
for cirrhotic liver disease or any cancer (n = 68), as well as wom-
en who were pregnant (n = 25), were excluded. Individuals with 
low BMI (< 18.5 kg/m
2) and incomplete data on anthropomet-
ric measurements or test results were also excluded (n = 790). 
A total of 4,573 subjects were included in the final statistical 
analysis. 
Study measurements
The survey consists of a health interview survey and a health 
examination survey. The survey collected data via face-to-face 
interviews inside the households and by direct standardized 
physical examinations conducted in specially equipped mobile 
examination centers. The sequence of the health survey admin-
istration involved intake, receipt of informed consent, blood 
pressure (BP) measurement, anthropometric measurement, 
blood sampling, and completion of the questionnaire. A stan-
dardized questionnaire regarding age, gender, socioeconomic 
characteristics, medical history, current drug use, smoking habit, 
alcohol consumption, and other lifestyle risk factors was pre-
pared. Monthly income was defined as the individual’s share of 
the total household income per month. Household equivalent 
income was calculated by summing up the monthly income of 
all household members and later dividing this sum by the square 
root of the household size. The participants were classified as 
current smokers if they smoked currently and nonsmokers if 
they had never smoked or had smoked previously but had quit. 
Likewise, alcohol consumption was categorized as those who 
ingested alcohol ≥ 1 time or < 1 time per month according to 
public health index. Physical activity, as assessed by the inter-
national physical activity questionnaire (IPAQ) (12), was classi-
fied into quartiles.
  BP was measured 3 times with 5-min intervals using a stan-
dard mercury sphygmomanometer (Baumanometer
®, WA Baum 
Co. Inc., Copiague, NY, USA). The average of the second and 
third measurements was used as the final BP. Anthropometric 
data, including height, body weight, and WC, were measured 
according to standardized guidelines. Height was measured in 
the erect position in centimeters with the head and hip touch-
ing the wall by mobile anthropometer (SECA 225
®, SECA Deut-
chland, Hamburg, Germany). Body weight was measured in  
kilograms by mobile scale (GL-6000-20
®, CASKOREA, Seoul, 
Korea) while the patient was dressed in a light gown without 
shoes. Using a fiberglass tape measure (SECA 200
®, SECA Deut-
chland), WC was measured in tenths of a centimeter without 
compression of the soft tissue along the middle horizontal line 
between the inferior margin of the last rib and the iliac crest. The 
feet were 25-30 cm apart in a stable standing position for this 
measurement. BMI was calculated by dividing the body weight 
by the height squared (kg/m
2). Fasting plasma glucose (FPG), 
total cholesterol (T-C), triglyceride (TG), and high density lipo-
protein cholesterol (HDL-C) were measured after a fasting period 
of at least 8 hr by using the autoanalyzer (ADVIA 1650
®, Bayer, 
Tarrytown, NY, USA).
  The obesity phenotype was classified by BMI and WC: with 
BMI, ≥ 18.5 and < 25.0 kg/m
2 was normal and ≥ 25.0 kg/m
2 was 
obese and with WC, < 90 cm in men or < 80 cm in women was 
normal and ≥ 90 cm in men or ≥ 80 cm in women was obese. 
Subsequently, the data were categorized into 4 groups such as 
normal BMI/normal WC (group A), normal BMI/obese WC 
(group B), obese BMI/normal WC (group C), and obese BMI/
obese WC (group D).
  To determine individuals’ 10-yr risk of CHD, we used the Fram-
ingham risk model. With the Framingham algorithm as outlined 
by Wilson et al. (13), a global risk score was calculated based on 
categorical values of age, gender, T-C, HDL-C, BP, smoking, and 
diabetes. Diabetes was defined as a FPG level of  ≥ 126 mg/dL or 
currently being treated with insulin or oral hypoglycemic agents.
Statistical analysis
Statistical analyses were performed using SPSS version 18.0 (SPSS 
Inc., Chicago, IL, USA) software packages. All estimates were 
calculated based on sample weights, which were evaluated by 
taking into consideration the sampling rate, response rate, and 
age and gender proportions of the reference population. The 
analysis was adjusted for the complex sample design of the sur-
vey. Continuous data were presented as means and standard 
errors (SE), and categorical data as frequencies and SE or 95% 
confidence intervals (CIs), as appropriate. Comparisons across 
obesity phenotype groups were made using the Student’s t-test 
for continuous data and the chi-squared test for categorical data. 
The distribution of the Framingham risk score (low < 6%, mod-
erate 6%- < 10%, moderately high 10%- < 20% and high ≥ 20%) 
by obesity phenotype groups was also presented. Multiple logis-
tic regression analyses were used to analyze relations between 
moderately high or high 10-yr CHD risk and obesity phenotype 
groups. All analyses except Table 1 were divided by gender. All 
tests were two-sided and P values of < 0.05 were considered Park YS, et al.  •  Obesity Phenotype and Coronary Heart Disease Risk
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statistically significant.
Ethics statement
The present study protocol was reviewed and approved by the 
institutional review board of Busan Paik Hospital (IRB No. 11-
146). All of the participants in this survey signed and submitted 
an informed consent.
RESULTS
The means of age, BMI, and WC of the subjects were 49.1 yr (SE 
0.3 yr), 24.1 kg/m
2 (SE 0.1 kg/m
2), and 82.8 cm (SE 0.2 cm), re-
spectively, and 57.2% (n = 2,615) of the sample was female. The 
number of subjects with obese BMI was 1,572 (34.7%) and the 
number of subjects with obese WC was 1,890 (37.3%). The num-
ber of subjects in obesity phenotype groups according to BMI 
and WC were 2,361 (54.0%, group A), 640 (11.3%, group B), 322 
(8.7%, group C), and 1,250 (26.0%, group D), respectively.
  The descriptive characteristics of the study population are con-
tained within Table 1. Subjects with obese WC were older (P <  
0.001) and had higher frequencies of being female and having a 
lower education level (< 12 yr) than normal WC subjects in both 
BMI groups. Subjects with normal WC were more likely to be 
smokers and more frequently reported alcohol consumption 
than the obese WC group regardless of BMI category. The fre-
quencies of current treatment for hypertension, diabetes, and 
dyslipidemia were higher in subjects with obese WC than with 
normal WC in both BMI categories. For individuals with normal 
BMI, the mean levels of BP, FPG, T-C, TG, and 10-yr CHD risk 
score were higher and that of HDL-C were lower in subjects with 
obese WC than those in the normal WC group. For individuals 
with obese BMI, subjects with obese WC had higher systolic BP, 
FPG, T-C, and 10-yr CHD risk scores than those in the normal 
WC group, although there were no differences in diastolic BP, 
TG, HDL-C between both WC categories.
  The frequency of the components used in the Framingham 
risk model for each of the obesity phenotype groups by gender 
are presented in Table 2. In this study population, categorical 
values of age (≥ 40 yr in men or ≥ 45 yr in women), T-C (≥ 200 
mg/dL), HDL-C (< 45 mg/dL in men or < 50 mg/dL in women), 
BP (≥ 130/85 mmHg in men or ≥ 140/90 mmHg in women), 
smoking, and diabetes were found in 63.8% (n = 3,018), 35.8% 
(n = 1,670), 55.5% (n = 2,589), 20.9% (n = 919), 26.6% (n = 1,014), 
and 8.1% (n = 404), respectively. For men and women, the prev-
Table 1. General characteristics of study population by obesity indices (n = 4,573)
Variables
Normal BMI Obese BMI
No  
(Weighted %)
Normal WC  
(n = 2,361)
Obese WC 
(n = 640)
P value
No  
(Weighted %)
Normal WC 
(n = 322)
Obese WC 
(n = 1,250)
P value
Age (yr) 45.8 (0.3) 52.0 (0.6) < 0.001 44.0 (0.5) 49.9 (0.4) < 0.001
Gender (Female) 1,778 (53.5) 47.9 (1.1) 79.8 (1.8) < 0.001 837 (42.5) 13.8 (2.1) 52.2 (1.6) < 0.001
Marital status (Single) 518 (16.8) 16.3 (1.1) 19.2 (1.5) 0.071 279 (16.0) 12.8 (2.3) 17.0 (1.3) 0.129
Education ( < 12 yr) 1,136 (31.3) 27.1 (1.4) 51.3 (2.7) < 0.001 740 (38.2) 24.3 (2.9) 42.9 (1.9) < 0.001
Equivalent income* ( × 10
4 won)
    Lowest quartile
    Highest quartile
 
670 (18.2)
762 (29.4)
172.0 (7.1)
17.1 (1.1)
30.6 (1.8)
185.7 (30.2)
24.0 (2.1)
23.3 (2.6)
0.590  
424 (21.5)
348 (25.5)
198.1 (33.2)
12.7 (2.1)
29.2 (3.3)
151.8 (7.1)
24.5 (1.6)
24.2 (1.8)
0.175
Smoking 662 (25.7) 28.3 (1.0) 13.5 (1.7) < 0.001 352 (28.1) 40.5 (3.2) 23.9 (1.5) < 0.001
Alcohol consumption ( ≥ 1/month) 1,635 (58.9) 61.6 (1.1) 46.2 (2.4) < 0.001 845 (61.5) 75.0 (2.6) 56.9 (1.7) < 0.001
Physical activity (METs for week)
   Lowest quartile
   Highest quartile
  
765 (26.2)
746 (23.7)
2,507 (79)
24.7 (1.1)
24.2 (1.2)
2,240 (142)
33.5 (2.4)
21.6 (2.0)
0.050
 
   
394 (25.1)
383 (24.2)
2,669 (163)
22.6 (2.7)
25.8 (2.6)
2,448 (103)
26.0 (1.5)
23.7 (1.5)
0.238
Antihypertensive drug use 366 (10.2) 7.8 (0.6) 21.7 (1.8) < 0.001 384 (20.5) 10.0 (1.9) 24.0 (1.4) < 0.001
Hypoglycemic agents use 129 (3.6) 2.8 (0.3) 7.7 (1.4) < 0.001 113 (6.2) 3.3 (1.1) 7.2 (0.8) 0.021
Antidyslipidemic drug use 73 (2.0) 1.3 (0.2) 5.2 (0.9) < 0.001 71 (3.7) 0.8 (0.5) 4.6 (0.7) 0.002
Body mass index (kg/m
2) 22.05 (0.04) 23.76 (0.04) < 0.001 26.04 (0.05) 27.70 (0.07) < 0.001
Waist circumference (cm) 76.9 (0.2) 85.8 (0.2) < 0.001 85.3 (0.2) 92.9 (0.2) < 0.001
Systolic blood pressure (mmHg) 112.1 (0.4) 117.6 (0.9) < 0.001 117.3 (0.8) 121.6 (0.6) < 0.001
Diastolic blood pressure (mmHg) 74.3 (0.3) 75.9 (0.5) 0.004 80.1 (0.7) 80.2 (0.4) 0.916
Fasting plasma glucose (mg/dL) 95.9 (0.5) 100.3 (1.1) < 0.001 97.7 (0.9) 106.1 (0.9) < 0.001
Total cholesterol (mg/dL) 184.6 (0.7) 194.2 (1.5) < 0.001 196.1 (2.0) 199.0 (1.3) 0.206
Triglyceride (mg/dL) 125.7 (2.8) 138.2 (4.6) 0.013 177.1 (8.5) 177.0 (4.5) 0.993
HDL-cholesterol (mg/dL) 49.0 (0.3) 47.3 (0.5) 0.001 44.0 (0.5) 44.9 (0.4) 0.176
10-yr CHD risk (%)
   ≥ 10
   ≥ 20
 
709 (19.9)
180 (4.1)
5.4 (0.1)
18.6 (1.0)
3.6 (0.4)
7.0 (0.3)
25.9 (2.0)
6.6 (1.1)
< 0.001
< 0.001
0.001
 
543 (31.9)
126 (6.4)
7.0 (0.3)
26.9 (2.8)
2.8 (0.8)
8.0 (0.2)
33.6 (1.6)
7.7 (0.9)
0.010
0.048
0.001
Data expression as estimated mean or estimated percent (standard error), as appropriate. P values are those of Student’s t-test or chi-squared test. *Equivalent income =  
monthly household income/  family size. BMI, body mass index; CHD, coronary heart diseases; HDL-cholesterol, high density lipoprotein cholesterol; MET, metabolic equivalent 
of task; WC, waist circumference.Park YS, et al.  •  Obesity Phenotype and Coronary Heart Disease Risk
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alence of high T-C, low HDL-C, and high BP was lowest in group 
A (normal BMI/normal WC) and highest in group D (obese BMI/ 
obese WC). Subjects with ages of ≥ 40 yr in men or ≥ 45 yr in 
women were higher in the obese WC groups than were those in 
normal WC groups. The prevalence of diabetes was higher in 
the obese WC groups than in normal WC groups regardless of 
gender. Group A (normal BMI/normal WC) in men and group 
B (normal BMI/obese WC) in women had high frequencies of 
smokers compared to other groups; however, there were no sig-
nificant differences between the obesity phenotype groups.
  Fig. 1. shows the distribution of Framingham risk across obe-
sity phenotype groups by gender. The means of 10-yr CHD risk 
were 9.37% (SE 0.27%) in men and 4.48% (SE 0.15%) in women, 
and there were no significant differences only between group A 
(normal BMI/normal WC) and group C (obese BMI/normal WC) 
in men and women (not shown in the figure). Men and women 
in group A (normal BMI/normal WC) had the lowest risk for 
CHD with 50.2% and 89.2% in the < 6% risk category, respec-
tively. Men in group B (normal BMI/obese WC) had the highest 
risk over the next 10 yr (21.3% with ≥ 20% CHD risk), whereas 
women in group D (obese BMI/obese WC) had the highest risk 
(5.0% with ≥ 20% 10-yr CHD risk). Subjects with obese WC had 
a lower proportion of low risk and a higher proportion of high 
risk for CHD compared to the normal WC group, regardless of 
BMI category. In both men and women, the proportions with 
high CHD risk status increased more than six-fold from the low-
est group to the highest group (3.1%-21.3%, in group C vs group 
B and 0.7%-5.0%, in group A vs group D, respectively, each P <  
0.001 across obesity phenotype groups).
  The adjusted odds ratios (ORs) for the ≥ 10% or ≥ 20% 10-yr 
CHD risk were calculated by multiple logistic regression analy-
sis (Table 3). Education level, equivalent income, alcohol con-
sumption, physical activity, antihypertensive drug use, and an-
tidyslipidemic drug use for the 4 obesity phenotype groups as 
classified by BMI and WC were included as independent vari-
ables in this model. Relative to those in group A (normal BMI/
Table 2. Prevalence of components used in the Framingham risk model for the obesity phenotype groups by gender
Parameters by gender Group A Group B Group C Group D P value
Men (n = 1,958)
   Age ≥ 40 yr
   T-C ≥ 200 mg/dL
   HDL-C < 45 mg/dL
   BP ≥ 130/85 mmHg
   Diabetes
   Smoker
(n = 1,115)
67.1 (63.2-70.8)
31.1 (28.1-34.1)
50.3 (46.6-54.0)
23.5 (20.6-26.8)
7.6 (6.1-9.6)
48.9 (45.8-52.0)
(n = 108)
89.1 (78.3-94.8)
43.5 (32.9-54.7)
66.8 (55.3-76.6)
38.5 (28.0-50.1)
19.5 (12.2-29.7)
38.6 (28.7-49.6)
(n = 260)
65.1 (57.8-71.7)
45.0 (38.3-51.9)
61.8 (54.7-68.4)
35.4 (28.9-42.4)
6.2 (3.7-10.0)
46.5 (39.7-53.5)
(n = 475)
71.7 (66.8-76.0)
45.4 (40.6-50.3)
68.5 (63.5-73.0)
44.0 (39.0-49.2)
12.4 (9.4-16.3)
45.2 (40.3-50.1)
 
0.002
< 0.001
< 0.001
< 0.001
< 0.001
0.293
Women (n = 2,615)
   Age ≥ 45 yr
   T-C ≥ 200 mg/dL
   HDL-C < 50 mg/dL
   BP ≥ 140/90 mmHg
   Diabetes
   Smoker
(n = 1,246)
45.9 (42.5-49.4)
28.0 (25.2-31.1)
44.3 (41.2-47.5)
5.7 (4.5-7.3)
2.1 (1.5-3.0)
5.8 (4.4-7.6)
(n = 532)
69.1 (63.7-74.1)
38.8 (34.6-43.3)
60.2 (55.2-65.0)
12.3 (9.0-16.4)
10.5 (7.4-14.6)
7.1 (4.7-10.6)
(n = 62)
45.8 (32.6-59.5)
33.5 (20.6-49.5)
58.3 (44.2-71.1)
16.2 (7.9-30.4)
-
2.8 (0.7-10.5)
(n = 775)
70.4 (66.3-74.2)
43.7 (40.0-47.5)
66.6 (62.5-70.4)
18.1 (15.1-21.7)
14.8 (12.2-17.8)
4.3 (2.9-6.4)
  
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
0.258
Data expression as estimated percent (95% confidence interval). P values are those of chi-squared test. Group A, 18.5 ≤ BMI < 25.0 (kg/m
2) and WC < 90 cm in men or < 80 cm 
in women; Group B, 18.5  ≤ BMI < 25.0 (kg/m
2) and WC ≥ 90 cm in men or ≥ 80 cm in women; Group C, BMI ≥ 25.0 kg/m
2 and WC < 90 cm in men or < 80 cm in women; 
Group D, BMI ≥ 25.0 kg/m
2 and WC ≥ 90 cm in men or ≥ 80 cm in women. BP, blood pressure; T-C, total cholesterol; other abbreviations as Table 1.
Fig. 1. Framingham risk score category within the obesity phenotype groups according to body mass index and waist circumference by gender (P < 0.001 across obesity phe-
notype groups). Normal BMI, 18.5 ≤ BMI < 25.0 (kg/m
2); Obese BMI, BMI ≥ 25.0 kg/m
2; Normal WC, WC < 90 cm in men or < 80 cm in women; Obese WC, WC ≥ 90 cm in 
men or ≥ 80 cm in women. BMI, body mass index; WC, waist circumference.
Normal BMI/Normal WC
Normal BMI/Obese WC
Obese BMI/Normal WC
Obese BMI/Obese WC
Low ( < 6%) Moderate (6% - < 10%) Moderately high (10% - < 20%) High ( ≥ 20%)
Women
(%)
  0  20  40  60  80  100
89.2
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18.3 12.8
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0.7
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(%)
100  80  60  40  20  0
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normal WC), significantly higher ORs of ≥ 10% or ≥ 20% 10-yr 
CHD risk were observed for subjects in group B (normal BMI/
obese WC) or group D (obese BMI/obese WC). The adjusted ORs 
of male subjects in group B (normal BMI/obese WC) were higher 
than those in group D (obese BMI/obese WC), whereas the ad-
justed ORs of female subjects in group D (obese BMI/obese WC) 
were higher than in the other obesity phenotype groups. The 
adjusted ORs of the subjects in group C (obese BMI/normal WC) 
for the ≥ 10% or ≥ 20% 10-yr CHD risk were not significantly 
higher compared to those in group A (normal BMI/normal WC).
 
DISCUSSION
The purpose of this study was to evaluate the independent asso-
ciation of obesity phenotypes represented by BMI and WC with 
CHD risk as estimated by the Framingham risk model. BMI and 
WC have been widely used as diagnostic indexes of obesity in 
clinical practice. Some have a normal BMI but an obese WC, 
whereas others have an obese BMI but a normal WC. It is con-
troversial whether individuals whose BMI and WC are conflict-
ing are associated with cardiovascular risk. In this study involv-
ing hypothesis testing, the null hypothesis was that the obesity 
phenotype groups presented by BMI and WC are similarly pre-
dictive of CHD risk, while the alternative was that there are het-
erogeneities among the obesity phenotype groups, particularly 
in normal BMI/obese WC or obese BMI/normal WC group.
  The percentage of central obesity assessed by WC was 37.3%, 
which was higher than the percentage of obesity based on BMI 
(34.7%). In this study, the prevalence of central obesity in wom-
en was obviously higher than that in men. Subjects with central 
obesity were older and had a higher frequency of being females 
than the normal WC group, regardless of general obesity assessed 
by BMI. It is well known that when comparing subjects who have 
similar BMIs, older persons would have more body fat than do 
younger persons and that women have more body fat than do 
men (14, 15). Hauner et al. (16) has also reported that the prev-
alence of obesity increased notably with age while women had 
an increased WC more often than men.
  In our study, the obese WC in both men and women was as-
sociated with CHD risk without reference to the level of BMI. 
The superiority between BMI and WC in estimating cardiovas-
cular risk has been controversial among some previous reports. 
Satoh et al. (3) reported that both BMI and WC could equally 
effectively predict the presence of multiple cardiovascular risk 
factors in a Japanese population. Lear et al. (17) suggested that 
the distribution of body fat in Asians differed from that of Cau-
casians and that BMI might be superior in assessing visceral 
obesity in Asians than in Caucasians. On the other hand, WC is 
considered to be a better predictor of cardiovascular risk than 
BMI (18-20). WC is related with abdominal fat, which is a strong 
indicator of cardiovascular risk independent of total body fat 
(21, 22). BMI is associated with body fat content but has several 
limitations in estimating obesity for some individuals. Some 
muscular men without excess body fat could be overestimated 
as obese, whereas some elderly or women with decreased lean 
body mass could be underestimated as normal (23, 24). Find-
ings of many studies are consistent in that WC is a better predic-
tor of obesity-related diseases in the elderly than in younger in-
dividuals and also in women than in men (25-27). The predict-
ability of anthropometric indexes on obesity-related diseases 
could be a function of age- and gender-related differences in 
body fat distribution.
  In addition, we found that there was a small but significant 
proportion of the Korean population whose BMI and WC pre-
sented conflicting information. One-fifth of the subjects were 
categorized into the conflicting obesity groups (group B or C). 
The proportion of female subjects with normal BMI and obese 
WC was higher than that with obese BMI and normal WC, while 
the reverse trend was true for men. Subjects with only central 
obesity but normal BMI (group B) were significantly associated 
with increased CHD risk, whereas those with only obese BMI 
without central obesity (group C) were not associated with CHD 
risk. Two previous reports have clearly shown that patients with 
a high WC and low BMI are at high risk of cardiovascular death. 
Zeller et al. (28) demonstrated that neither BMI nor WC inde-
pendently predicted death after acute myocardial infarction and 
that the group of patients with high WC but low BMI had an in-
creased 1-yr death rate. In a large European cohort study, the 
positive association between abdominal fat distribution and the 
high risk of mortality over 9.7 yr tended to be stronger among 
participants with a lower BMI than among those with a higher 
BMI (29). Interestingly, CHD risk in men with only central obe-
sity but normal BMI (group B) was higher than that of subjects 
with obese BMI and obese WC. Our study showed that males in 
group B (normal BMI/obese WC) had the highest frequency of 
Table 3. Multiple logistic regression examining the 10-yr coronary heart disease risk 
calculated by Framingham model and obesity phenotype classified by body mass     
index and waist circumference
Gender/Group
≥ 10% 10-yr CHD risk ≥ 20% 10-yr CHD risk
OR (95% CI) P value OR (95% CI) P value
Men
   Group A
   Group B
   Group C
   Group D
 
1 (reference)
2.93 (1.70-5.04)
0.85 (0.55-1.31)
1.91 (1.40-2.61)
 
 
< 0.001
0.449
< 0.001
 
1 (reference)
3.10 (1.49-6.46)
0.52 (0.26-1.05)
1.70 (1.16-2.47)
 
 
0.003
0.067
0.006
Women
   Group A
   Group B
   Group C
   Group D
 
1 (reference)
1.69 (1.01-2.81)
0.80 (0.25-2.52)
1.94 (1.24-3.04)
 
0.045
0.702
0.004
 
1 (reference)
2.72 (0.97-7.62)
1.62 (0.19-13.84)
3.92 (1.75-8.78)
  
  
0.058
0.658
0.001
Adjusted for education level, equivalent income, alcohol consumption, physical activi-
ty, antihypertensive drug use, and antidyslipidemic drug use. Definition of group A, B, 
C, and D are same as in Table 2. CI, confidence interval; OR, odds ratio; other abbre-
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the age component (≥ 40 yr) and diabetes prevalence among 
the subjects in the 4 obesity phenotype groups.
  One of the possible reasons for the sex difference may be the 
effect of estrogen on the cardiovascular risk factors (i.e., the pro-
tective effects of estrogen on plasma lipids may be stronger than 
the variability in adiposity). Another possible reason is the sex 
difference in the biology of lower body fat. It has been shown 
that thigh fat is associated with higher plasma HDL-cholesterol 
levels and a lower incidence of diabetes only in females. Most 
women have a gynoid profile of fat deposition with more adi-
posity in the lower body segment. However, the present study 
examined the association between the presence of risk factors 
and total adiposity but not body fat distribution. Variations in 
abdominal fat may explain the fact there was almost no differ-
ence across adiposity quintiles among females with normal 
weight, as Ruderman et al. (30) suggested.
  The present study has limitations. First, imperfections of the 
cross-sectional design include the fact that the survey was ac-
complished on a single visit, which cannot account for inherent 
variability in some laboratory tests and measurements. Further, 
the cardiovascular risk estimated by the Framingham risk score 
is not the actual CHD event. Second, only two obesity indexes 
were evaluated in this study. Therefore, the associations with 
cardiovascular risk and other anthropometric measurements 
such as waist-hip ratio or waist-to-height ratio, or more objective 
surrogates of body fat distribution, cannot be discussed. Finally, 
the Framingham risk model used to determine individuals’ 
global risk of experiencing a future cardiovascular event may be 
overestimated in Koreans with significantly different genetic 
profiles or social and environmental backgrounds. In this study, 
however, the distribution of the Framingham risk score was used 
as a stratification tool of CHD risk, and not in calculating the ab-
solute risk scores of CHD. Despite these limitations, our study 
has an advantage in measuring the obesity phenotype via a sim-
ple and inexpensive manner to predict CHD risk in a relatively 
large number of subjects. The survey was recently performed in 
a nationwide, population-based, and representative sample of 
Koreans, and all analyses in this study were completely based 
on sample weights and adjusted for the complex sample design 
of the survey. Thus, these results can be generalized for the en-
tire Korean adult population.
  In conclusion, central obesity assessed by WC was related to 
increased CHD risk regardless of the level of BMI in Korean 
adults. The CHD risk in subjects with only obese BMI without 
central obesity, on the other hand, was not significantly higher. 
In addition, men with only central obesity but normal BMI 
tended to be associated with moderately higher or higher risk 
of CHD than those with obese BMI and obese WC. The results 
of this study suggest that the obesity phenotype related with 
both general obesity and central obesity should be considered 
in estimating CHD risk by anthropometric measures of obesity. 
Considering obesity phenotype by gender differences may also 
result in an improved approach for the assessment of obesity-
related cardiovascular risk.
 
REFERENCES
1. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. 
The incidence of co-morbidities related to obesity and overweight: a sys-
tematic review and meta-analysis. BMC Public Health 2009; 9: 88.
2. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures 
of abdominal obesity assessed for visceral adiposity and relation to coro-
nary risk. Int J Obes Relat Metab Disord 2004; 28: 1018-25.
3. Satoh H, Kishi R, Tsutsui H. Body mass index can similarly predict the 
presence of multiple cardiovascular risk factors in middle-aged Japanese 
subjects as waist circumference. Intern Med 2010; 49: 977-82.
4. Ryan MC, Fenster Farin HM, Abbasi F, Reaven GM. Comparison of waist 
circumference versus body mass index in diagnosing metabolic syndrome 
and identifying apparently healthy subjects at increased risk of cardio-
vascular disease. Am J Cardiol 2008; 102: 40-6.
5. Janiszewski PM, Janssen I, Ross R. Does waist circumference predict dia-
betes and cardiovascular disease beyond commonly evaluated cardio-
metabolic risk factors? Diabetes Care 2007; 30: 3105-9.
6. Zhu S, Heymsfield SB, Toyoshima H, Wang Z, Pietrobelli A, Heshka S. 
Race-ethnicity-specific waist circumference cutoffs for identifying cardio-
vascular disease risk factors. Am J Clin Nutr 2005; 81: 409-15.
7. Huang KC, Lee MS, Lee SD, Chang YH, Lin YC, Tu SH, Pan WH. Obesity 
in the elderly and its relationship with cardiovascular risk factors in Tai-
wan. Obes Res 2005; 13: 170-8.
8. Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, 
Korinek J, Jensen MD, Parati G, Lopez-Jimenez F. Normal weight obesi-
ty: a risk factor for cardiometabolic dysregulation and cardiovascular 
mortality. Eur Heart J 2010; 31: 737-46.
9. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Met-
abolic and body composition factors in subgroups of obesity: what do we 
know? J Clin Endocrinol Metab 2004; 89: 2569-75.
10. Tanaka S, Togashi K, Rankinen T, Pérusse L, Leon AS, Rao DC, Skinner 
JS, Wilmore JH, Bouchard C. Is adiposity at normal body weight relevant 
for cardiovascular disease risk? Int J Obes Relat Metab Disord 2002; 26: 
176-83.
11. Ying X, Song ZY, Zhao CJ, Jiang Y. Body mass index, waist circumference, 
and cardiometabolic risk factors in young and middle-aged Chinese 
women. J Zhejiang Univ Sci B 2010; 11: 639-46.
12. IPAQ core group. Guidelines for Data Processing and Analysis of the Inter-
national Physical Activity Questionnaire (IPAQ) - Short and Long Forms. 
(Revised November 2005) Available at http://www.ipaq.ki.se/scoring.
htm [accessed on 6 May 2011].
13. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel 
WB. Prediction of coronary heart disease using risk factor categories. Cir-
culation 1998; 97: 1837-47.
14. Lei SF, Liu MY, Chen XD, Deng FY, Lv JH, Jian WX, Xu H, Tan LJ, Yang YJ, 
Wang YB, Xiao SM, Sun X, Jiang C, Guo YF, Guo JJ, Li YN, Liu YJ, Deng 
HW. Relationship of total body fatness and five anthropometric indices 
in Chinese aged 20-40 years: different effects of age and gender. Eur J Clin 
Nutr 2006; 60: 511-8.Park YS, et al.  •  Obesity Phenotype and Coronary Heart Disease Risk
http://jkms.org   249 http://dx.doi.org/10.3346/jkms.2012.27.3.243
15. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield 
SB. How useful is body mass index for comparison of body fatness across 
age, sex, and ethnic groups? Am J Epidemiol 1996; 143: 228-39.
16. Hauner H, Bramlage P, Losch C, Jockel KH, Moebus S, Schunkert H, 
Wasem J. Overweight, obesity and high waist circumference: regional dif-
ferences in prevalence in primary medical care. Dtsch Arztebl Int 2008; 
105: 827-33.
17. Lear SA, Humphries KH, Kohli S, Birmingham CL. The use of BMI and 
waist circumference as surrogates of body fat differs by ethnicity. Obesity 
(Silver Spring) 2007; 15: 2817-24.
18. Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Waist 
circumference vs body mass index for prediction of disease risk in post-
menopausal women. Int J Obes Relat Metab Disord 2001; 25: 1183-8.
19. Charlton KE, Schloss I, Visser M, Lambert EV, Kolbe T, Levitt NS, Temple 
N. Waist circumference predicts clustering of cardiovascular risk factors 
in older South Africans. Cardiovasc J S Afr 2001; 12: 142-50.
20. Thomas GN, Ho SY, Lam KS, Janus ED, Hedley AJ, Lam TH; Hong Kong 
Cardiovascular Risk Factor Prevalence Study Steering Committee. Im-
pact of obesity and body fat distribution on cardiovascular risk factors 
in Hong Kong Chinese. Obes Res 2004; 12: 1805-13.
21. Testa G, Cacciatore F, Galizia G, Della-Morte D, Mazzella F, Langellotto 
A, Russo S, Gargiulo G, De Santis D, Ferrara N, Rengo F, Abete P. Waist 
circumference but not body mass index predicts long-term mortality in 
elderly subjects with chronic heart failure. J Am Geriatr Soc 2010; 58: 
1433-40.
22. Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS. Abdominal adi-
posity and clustering of multiple metabolic syndrome in White, Black 
and Hispanic Americans. Ann Epidemiol 2000; 10: 263-70.
23. Frankenfield DC, Rowe WA, Cooney RN, Smith JS, Becker D. Limits of 
body mass index to detect obesity and predict body composition. Nutri-
tion 2001; 17: 26-30.
24. Cho YG, Song HJ, Kim JM, Park KH, Paek YJ, Cho JJ, Caterson I, Kang JG. 
The estimation of cardiovascular risk factors by body mass index and body 
fat percentage in Korean male adults. Metabolism 2009; 58: 765-71.
25. Ho SC, Chen YM, Woo JL, Leung SS, Lam TH, Janus ED. Association be-
tween simple anthropometric indices and cardiovascular risk factors. Int 
J Obes Relat Metab Disord 2001; 25: 1689-97.
26. Jeong SK, Seo MW, Kim YH, Kweon SS, Nam HS. Does waist indicate dys-
lipidemia better than BMI in Korean adult population? J Korean Med 
Sci 2005; 20: 7-12.
27. Dobbelsteyn CJ, Joffres MR, MacLean DR, Flowerdew G. A comparative 
evaluation of waist circumference, waist-to-hip ratio and body mass in-
dex as indicators of cardiovascular risk factors. The Canadian Heart 
Health Surveys. Int J Obes Relat Metab Disord 2001; 25: 652-61.
28. Zeller M, Steg PG, Ravisy J, Lorgis L, Laurent Y, Sicard P, Janin-Manificat 
L, Beer JC, Makki H, Lagrost AC, Rochette L, Cottin Y; RICO Survey Work-
ing Group. Relation between body mass index, waist circumference, and 
death after acute myocardial infarction. Circulation 2008; 118: 482-90.
29. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad 
K, van der Schouw YT, Spencer E, Moons KG, Tjønneland A, Halkjaer J, 
Jensen MK, Stegger J, Clavel-Chapelon F, Boutron-Ruault MC, Chajes V, 
Linseisen J, Kaaks R, Trichopoulou A, Trichopoulos D, Bamia C, Sieri S, 
Palli D, Tumino R, Vineis P, Panico S, Peeters PH, May AM, Bueno-de-
Mesquita HB, van Duijnhoven FJ, Hallmans G, Weinehall L, Manjer J, 
Hedblad B, Lund E, Agudo A, Arriola L, Barricarte A, Navarro C, Marti-
nez C, Quirós JR, Key T, Bingham S, Khaw KT, Boffetta P, Jenab M, Ferrari 
P, Riboli E. General and abdominal adiposity and risk of death in Europe. 
N Engl J Med 2008; 359: 2105-20.
30. Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese,” 
normal-weight individual. Am J Clin Nutr 1981; 34: 1617-21.